We are live on ! Find out more
TCP

Tyndall Capital Partners Portfolio holdings

AUM $452K
1-Year Est. Return 26.52%
This Fund
S&P 500
This Quarter Est. Return
-37.73%
1 Year Est. Return
+26.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.89M
AUM Growth
+$3.05M
Cap. Flow
+$5.24M
Cap. Flow %
76.06%
Top 10 Hldgs %
100%
Holding
3
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TRAW icon
Traws Pharma
TRAW
+$5.24M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 71.91%
2 Financials 28.02%
3 Miscellaneous 0.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRAW icon
1
Traws Pharma
TRAW
$9.24M
$4.95M 71.91%
2,177
+1,804
+484% +$5.24M
MMAC
2
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
$1.93M 28.02%
72,552
– –
ONTXW
3
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
$5K 0.07%
390,624
– –

Similar funds

CCM
Cota Capital Management San Francisco, California $177K AUM 63.94% 1-Year Est. Return
HIP
Hatteras Investment Partners Raleigh, North Carolina $169K AUM 86.49% 1-Year Est. Return
BPWM
Black Point Wealth Management Naples, Florida $3.5M AUM 16.42% 1-Year Est. Return
NP
Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return
CP
Castalian Partners Excelsior, Minnesota $7.36M AUM
AI
Allostery Investments Stamford, Connecticut $7.85M AUM
CAWM
Capital A Wealth Management New Castle, Pennsylvania $8.94M AUM
ADIM
Alpha DNA Investment Management Columbia, Maryland $8.98M AUM 26.05% 1-Year Est. Return

Tyndall Capital Partners's Q2 2018 Portfolio in Review

As of Q2 2018, Tyndall Capital Partners held 3 positions worth $6.89M, up 79% from $3.84M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tyndall Capital Partners deployed $5.24M of net new capital in Q2 2018, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 72% of assets, up from 46% a quarter earlier, followed by Financials and Miscellaneous.

  • Tyndall Capital Partners added most to Traws Pharma in Q2 2018, an estimated $5.24M increase.
  • Tyndall Capital Partners's ten largest holdings make up 100% of its $6.89M portfolio in Q2 2018.
  • Tyndall Capital Partners opened 0 new positions and closed 0 in Q2 2018.
  • Tyndall Capital Partners's portfolio value rose 79% quarter-over-quarter to $6.89M.

Based on Tyndall Capital Partners's 13F filing for Q2 2018, filed 14 Aug 2018.